Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through interviews, clinical observation, and from hospital records. A total of 59 patients were included....
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Associação Brasileira de Divulgação Científica
2016-01-01
|
| Serija: | Brazilian Journal of Medical and Biological Research |
| Teme: | |
| Online pristup: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600705&lng=en&tlng=en |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|